ahn-12
mAbexperimentalADC
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2005 (NCT00618696)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Leukocyte common antigenBINDING AGENT
PTPRC binding agent
- Leukocyte common antigenINHIBITOR
PTPRC inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
- Payload
- 90-Yttrium
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109480 ↗
Also known as
- 90y-ahn-12
- ahn-12
- ahn-12
- y90 anti-cd45 monoclonal antibody ahn-12
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01207076 | Phase 1 | Dec 1, 2013 | University of Minnesota |
| NCT00618696 | Phase 1 | Jul 1, 2005 | University of Minnesota |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Minnesota | Academic/Hospital | 2 | 2 | 1 | 2005 |
1 organizations
Page 1 / 1